Salesforce (CRM)
NYSEInformation TechnologySoftware - ApplicationSnapshot 2026-07-07
$169.51+2.33%
Close 2026-07-07 · 1-day change
Reading CRM? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track CRM free→NYSEInformation TechnologySoftware - ApplicationSnapshot 2026-07-07
Reading CRM? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track CRM free→QuarterlyIQ Insights · CRM
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 14 valuation methods, at three horizons. Current price $169.51. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $170 CRM trades at 12× p/e, below its 38× p/e peer median. Our $261 fair value sits well above the price. We hold it with medium confidence: the peer anchor overstates how cheap it looks. Analysts target $215–$325. Not investment advice.
$215.00 – $325.00 (median $270.00) · 4 analysts · as of 2026-05-28
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
These describe the expectations embedded in the price, not a forecast of the move. Reverse-DCF base: $11.62/sh owner earnings.
Looks cheaper than most peers in the same business.
Cheaper than its own typical valuation.
Trailing four: 2026-Q1, 2026-Q2, 2026-Q3, 2027-Q1
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $270.00 | — | — | Analyst | high |
| dcf fcfe | 12M | $1038.44 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $1125.69 | — | — | Hist. CAGR | high |
| ddm gordon | 12M | $40.94 | — | — | TTM | high |
| graham number | 12M | $110.67 | — | — | TTM | high |
| Mgmt guidance | 12M | $302.18 | 38.0 | 7.96 | Mgmt | high |
| Peer EV/EBITDA | 12M | $168.42 | 14.4 | 14.13 | TTM | high |
| Peer P/FCF | 12M | $324.13 | 19.3 | 16.83 | TTM | high |
| Peer P/E | 12M | $525.77 | 38.0 | 13.85 | TTM | high |
| Peer P/S | 12M | $165.30 | 3.4 | 49.17 | TTM | high |
| PEG | 12M | $99.18 | 7.2 | 13.85 | TTM | high |
| residual income | 12M | $85.59 | — | — | TTM | high |
| Own P/E history | 12M | $359.09 | 25.9 | 13.85 | TTM | high |
| triangulated | 12M | $546.49 | 38.0 | 14.40 | Triangulated | high |
| Mgmt guidance | 3Y | $375.48 | 38.0 | 9.89 | Mgmt(prov.) | medium |
| Peer P/FCF | 3Y | $492.96 | 19.3 | 25.60 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $653.31 | 38.0 | 17.21 | Analyst | medium |
| Peer P/S | 3Y | $217.51 | 3.4 | 64.70 | guidance | medium |
| PEG | 3Y | $123.23 | 7.2 | 17.21 | Analyst | medium |
| Own P/E history | 3Y | $446.20 | 25.9 | 17.21 | Analyst | medium |
| Mgmt guidance | 5Y | $433.97 | 38.0 | 11.43 | Mgmt(prov.) | high |
| Peer P/FCF | 5Y | $651.93 | 19.3 | 33.86 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $755.09 | 38.0 | 19.89 | Analyst | high |
| Peer P/S | 5Y | $251.45 | 3.4 | 74.80 | guidance | high |
| PEG | 5Y | $142.43 | 7.2 | 19.89 | Analyst | high |
| Own P/E history | 5Y | $515.71 | 25.9 | 19.89 | Analyst | high |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.